Lize Xiong Selected Research

Brain Ischemia (Cerebral Ischemia)

1/2021	Activation of astroglial CB1R mediates cerebral ischemic tolerance induced by electroacupuncture.
8/2019	TREK-2 Mediates the Neuroprotective Effect of Isoflurane Preconditioning Against Acute Cerebral Ischemia in the Rat.
10/2018	Astrocyte Autophagy Flux Protects Neurons Against Oxygen-Glucose Deprivation and Ischemic/Reperfusion Injury.
12/2017	Electroacupuncture Alleviates Brain Damage Through Targeting of Neuronal Calcium Sensor 1 by miR-191a-5p After Ischemic Stroke.
1/2017	Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement.
1/2017	Cystatin C Is a Crucial Endogenous Protective Determinant Against Stroke.
9/2016	Elevated Expression of Carboxy-Terminal Modulator Protein (CTMP) Aggravates Brain Ischemic Injury in Diabetic db/db Mice.
6/2016	2-Arachidonylglycerol Protects Primary Astrocytes Exposed to Oxygen-Glucose Deprivation Through a Blockade of NDRG2 Signaling and STAT3 Phosphorylation.
2/2016	Estrogen replacement therapy-induced neuroprotection against brain ischemia-reperfusion injury involves the activation of astrocytes via estrogen receptor β.
1/2016	Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lize Xiong Research Topics

Disease

49	Brain Ischemia (Cerebral Ischemia) 01/2021 - 01/2003
42	Infarction (Infarctions) 08/2019 - 01/2003
32	Ischemia 01/2020 - 06/2005
31	Reperfusion Injury 08/2019 - 03/2010
17	Stroke (Strokes) 01/2021 - 02/2011
15	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017 - 01/2003
13	Inflammation (Inflammations) 09/2021 - 06/2010
13	Spinal Cord Ischemia 04/2014 - 04/2002
9	Ischemic Stroke 01/2021 - 07/2011
8	Wounds and Injuries (Trauma) 03/2017 - 02/2009
7	Pain (Aches) 01/2022 - 12/2008
7	Neurologic Manifestations (Neurological Manifestations) 01/2014 - 01/2003
7	Brain Infarction 11/2012 - 01/2003
6	Neoplasms (Cancer) 01/2021 - 05/2011
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2013
4	Cognitive Dysfunction 09/2021 - 08/2010
4	Myocardial Ischemia (Ischemic Heart Diseases) 06/2015 - 05/2011
4	Hypoxia (Hypoxemia) 07/2014 - 02/2011
4	Transient Ischemic Attack 01/2014 - 06/2009
4	Sepsis (Septicemia) 08/2010 - 10/2009
3	Glioma (Gliomas) 01/2021 - 01/2013
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2014 - 08/2010
3	Multiple Organ Failure (MODS) 11/2010 - 06/2010
2	Hyperalgesia 01/2022 - 06/2012
2	Memory Disorders (Memory Loss) 09/2021 - 07/2014
2	Brain Edema (Cerebral Edema) 01/2021 - 04/2015
2	Hemorrhagic Stroke 01/2021 - 04/2014
2	Knee Osteoarthritis 01/2019 - 05/2018
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 12/2017
2	Hypertension (High Blood Pressure) 01/2019 - 09/2015
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2018 - 04/2018
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2018 - 12/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 09/2012
2	Cerebral Infarction 09/2016 - 11/2011

Drug/Important Bio-Agent (IBA)

23	Neuroprotective AgentsIBA 08/2019 - 08/2010
22	Oxygen (Dioxygen)IBA 04/2019 - 04/2002
14	AntioxidantsIBA 12/2015 - 05/2006
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2009
11	Isoflurane FDA LinkGeneric 09/2021 - 04/2002
10	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2014 - 04/2010
10	EnzymesIBA 09/2013 - 05/2006
9	Sevoflurane (Ultane)FDA LinkGeneric 08/2019 - 10/2009
9	Small Interfering RNA (siRNA)IBA 10/2018 - 06/2009
9	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 01/2013
7	Messenger RNA (mRNA)IBA 01/2022 - 08/2010
7	ZymosanIBA 10/2013 - 10/2009
6	CannabinoidsIBA 01/2019 - 12/2009
6	Superoxide DismutaseIBA 01/2016 - 05/2006
5	salicylhydroxamic acid (SHAM)IBA 11/2021 - 05/2006
5	Peptides (Polypeptides)IBA 01/2021 - 02/2011
4	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 06/2005
4	Pharmaceutical PreparationsIBA 01/2021 - 04/2002
4	Therapeutic UsesIBA 01/2021 - 06/2014
4	Glutamic Acid (Glutamate)FDA Link 07/2020 - 01/2013
4	Anesthetics (Anesthetic Agents)IBA 08/2019 - 08/2010
4	CytokinesIBA 01/2019 - 10/2009
4	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2016 - 06/2008
4	HydrogenIBA 02/2013 - 07/2010
4	diazonaphthalenedisulfonic acid (NDS)IBA 02/2012 - 01/2003
4	Free RadicalsIBA 08/2011 - 03/2004
4	Cannabinoid Receptors (Cannabinoid Receptor)IBA 05/2011 - 06/2009
3	CatalaseIBA 12/2015 - 05/2006
3	AdiponectinIBA 11/2015 - 04/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2015 - 06/2012
3	Matrix Metalloproteinases (MMPs)IBA 04/2015 - 01/2013
3	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2014 - 04/2013
3	Malondialdehyde (Propanedial)IBA 07/2014 - 06/2012
3	Insulin (Novolin)FDA Link 07/2014 - 05/2013
3	ginsenoside RdIBA 07/2014 - 02/2011
3	Caspase 3 (Caspase-3)IBA 07/2014 - 06/2008
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 02/2014 - 06/2009
3	U 0126 (UO 126)IBA 01/2014 - 10/2010
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2013 - 06/2012
3	HMGB1 Protein (HMG1)IBA 01/2012 - 06/2009
2	Remifentanil (Ultiva)FDA Link 11/2021 - 09/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 11/2018
2	Adenosine Triphosphatases (ATPase)IBA 01/2021 - 01/2020
2	potassium channel protein TREK-1IBA 08/2019 - 05/2012
2	3-methyladenineIBA 04/2019 - 10/2018
2	Cystatin CIBA 04/2019 - 01/2017
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2019 - 09/2015
2	Iodoacetic AcidIBA 01/2019 - 05/2018
2	General AnestheticsIBA 01/2019 - 01/2012
2	NitrogenIBA 11/2018 - 03/2017
2	Sirolimus (Rapamycin)FDA Link 10/2018 - 01/2013
2	Biological ProductsIBA 08/2018 - 02/2011
2	MicroRNAs (MicroRNA)IBA 12/2017 - 12/2016
2	Glycogen Synthase (Synthase I)IBA 01/2017 - 02/2014
2	Phosphotransferases (Kinase)IBA 09/2016 - 11/2011

Therapy/Procedure

20	Therapeutics 01/2022 - 12/2008
20	Electroacupuncture 01/2021 - 01/2003
10	Acupuncture Points (Acupuncture Point) 01/2022 - 01/2003
5	Anesthesia 11/2021 - 01/2003
4	Ischemic Postconditioning 09/2013 - 11/2011
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2018 - 03/2010
3	Intraperitoneal Injections 01/2017 - 06/2008
2	Length of Stay 01/2022 - 12/2006
2	Analgesia 01/2022 - 05/2018
2	General Anesthesia 01/2019 - 01/2019
2	Radiofrequency Ablation 10/2018 - 04/2018